AESKU was founded in January 2000 by Dr. Torsten Matthias, a recognized scientist with over 20 years of experience in autoimmune diseases research. With the following timeline we will try to give a short overview about growth, milestones and evolution of the AESKU Company.
Year 2000 - 2002 2000 2000 2001 2001 2001 2002 2002 2002 2002 Year 2003 - 2005 2003 2003 2003 2003 2004 2004 2004 2005 Year 2006 - 2008 2006 2006 2006 2006 2007 2007 2007 2007 2007 2007 2008 2008 2008 Year 2009 - 2011 2009 2009 2010 2010 2011 2011 2011 2011 Year 2012 - 2014 2012 2012 2012 2012 2013 2013 2013 2013 2013 2013 2013 2014 2014 2014 2014 2014 2014 Year 2015 2015 2015 2015 2015 2015 Year 2016 2016 2016 2016 2016 Year 2017 2017 2017 2017 2017 2017
Foundation of AESKULAB.DIAGNOSTICA starting with 5 employees
2000
"Pioniergeist 2000" for courageous startup of the company
Development of the first 20 products (dsDNA, TG)
2001
First Version of the company homepage "aeskulab.de" online
CE and ISO certification
"Innovations Preis 2001" for the patented alpha-Fodrin kit
Product range overall 40 products
Setup of the AESKULAB distribution network
Czech republic was the first country to import and distribute the AESKULISA product line
2002
First participation in main trade shows (MEDICA in Germany and AACC in Canada) and at the 3rd scientific meeting at International Congress on Autoimmunity in Switzerland
International patent for lupus nephritis in-vivo therapy
Product range overall 80 products
AESKU.Diagnostics distribution network extended to 12 countries
Foundation of the AESKU.GROUP: Company name changed from AESKU DIAGNOSTIKA to AESKU.DIAGNOSTICS
First FDA cleared products
2003
Establishment of the "First Chair on Autoimmunity" in Tel Aviv
AESKULISA tTg New Generation was launched
2004
The 1st AESKU.AWARD was granted at the 4th CONGRESS of AUTOIMMUNITY in Hungary
Publication of the AESKU.SCIENCE, Issue No.1
Patented SLA AESKULISA kit for Autoimmune Hepatitis and ANA HEP-2 AESKULISA for rheumatoid diseases were launched
Product range overall 111 products
Foundation of AIRA e.V. (Association for Interdisciplinary Research in Autoimmunity)
2005
AESKUSLIDES product line for IFA was launched
2006
Opening of the AESKU.KIPP Institute in May 2006
Foundation of the first subsidairy, "AESKU.INC" located in Atlanta
The AESKU.AWARD was granted for the 2nd time at the 5th CONGRESS of AUTOIMMUNITY in Italy
AESKULISA RA/CP kit for rheumatoid arthritis was launched
ASKULISA Lyme disease (Liquor and Sera) was launched
The 1st "YOUNG INVESTIGATOR AESKU.AWARD" was granted at APS Symposium in Italy
AESKU-KIPP Institute SUMMER SCHOOL
2007
Establishment of the AESKU Daycare Center
AESKU AUTOMATIC LINE was launched
Introduction of the HEMOSTASIS LINE
AESKULISA CCP kit was launched
International patent for multiple sclerosis therapy
Foundation of AESKU.SYSTEMS, the automation division of AESKU.GROUP
2008
Successful launch of the HELMED processor
"ISB SUCCESS AWARD 2008" from the federal state Rheinland-Pfalz, GERMANY
AESKU.INC Homepage was launched
2009
AESKU.DIAGNSOTICS receives the prestigious "FROST AND SULLIVAN STRATEGY AWARD"
Launch of the AESKU.SYSTEMS Homepage
AESKU reaches 70 dedicated employees
2010
AESKU.Diagnostics GmbH & Co. KG, awarded with the STEP Award 2010. Aesku was selected amongst 100 Biotech companies from all over Germany, Austria and Switzerland for its sustainable growth during the last years.
AESKULISA® MMP-3: A NEW PROGNOSTIC AND ACTIVITY MARKER FOR RHEUMATOID ARTHRITIS was launched.
AESKU celebrated its 10th anniversary with a company gathering in the astonishing city of Dresden.
Opening of the U.S. west coast office in San Francisco, California.
AESKU reached 87 dedicated employees
2011
AESKU.SYSTEMS launches HELIOS®, the first automated IFA processor + reader in the market.
AESKU.DIAGNOSTICS introduces AESKUBLOTS®, a new product line in immunoblot to complete the Autoimmunity portfolio and to complement the IFA and ELISA panels.
AESKU.SYSTEMS receives the “2011 European Autoimmune Diagnostics Product Differentiation Excellence Award”.
New booth designs at the major exhibitions in the USA and in Germany, featuring big screen Videoanimation and the Holorizon Display.
2012
The 5th AESKU.Award was granted, this time at the 8th CONGRESS of AUTOIMMUNITY in Spain
Relaunch of the AESKU.DIAGNOSTICS and the AEKU.SYSTEMS Homepage
The" SWR", a German TV station, features a documentation about AESKU (“Made in Rheinland-Pfalz”).
The HELMED, the LED’s Go-Microscope and different kits were seen in the TV-shows “Dr. House” and “Grey’s Anatomy”.
2012
AESKU develops the AESKU.SCAN software as solution for semiautomated analysis of AESKUBLOTS.
AESKU opened a sub-office in South America.
Launch of the AESKU middleware.
AESKU.SYSTEMS adds the MOTIC microscope to its portfolio, replacing the LED´s Go- Microscope.
Major Update of the AESKUSLIDES Product-Line
AESKU.SYSTEMS develops the 190 sample Rack for HELMED and HELIOS.
Launch of AESKULISA 25OH Vitamin D Total - An ELISA Test for the quantitative determination of 25-hydroxyvitamin D2 and D3 (25OH D2 and 25OH D3) levels in human serum.
AESKU.SYSTEMS launches the HELMED Blot Module. The HELMED is now the only instrument on the market able to process the “major three” (ELISA, IFA and BLOT) in the same machine.
2013
AESKU reaches 100 dedicated employees.
With the by AESKU initiated Lifetime Contribution to Autoimmunity Award Ms. Claire Dwoskin Dr. Marvin Fritzler Dr. Pier Luigi Meroni were awarded for their remarkable work in Autoimmune Research.
AESKU.SYSTEMS launches the automated analyzer for line immunoassays – the HELIA®. As a further development of the HELMED® system, it is capable to perform all immunoblot processing steps and is able to read and report immunoblot results.
Publishing of the Bioscientia Comparative Study with the content: “HELIOS® from AESKU.DIAGNOSTICS compared with IFT on HEp-2 cells from Euroimmun” by Dr. J. Blecken and Birgit Gierten.
AESKU.SYSTEMS releases the HELMED BLOT Module to extend the HELMED system with the Ability for BLOT Processing
Participation at the 9th annual Congress of Autoimmunity in Nizza with many new impressions and meeting of business partners.
2014
Acquiring of three innovative Electric Verhicles from Smart because AESKU believes in renewable energy and wants to prevent pollution.
"ISB SUCCESS AWARD 2014" for the HELIOS® from the federal state Rheinland-Pfalz, GERMANY
2015
AESKU established its new production facility in Buffalo (USA) to enhance the production of the AESKUSLIDES® product line.
AESKU was honored with the Innovationspreis 2015 of Rhineland-Palatinate.
For the first time, AESKU is initiating several workshops in Latin America and Malaysia for Customers and Distributors
AESKU’s local social commitment was honored by the “Tafel”, a german initiative against wasting food and for donating to deserving poor.
With all the benefits of our One-Concept we also aimed for our new goal – the One-Group.
In 2015 the companies AESKU.DIAGNOSTICS, AESKU.SYSTEMS, AESKU.THERAPY and the AESKU.KIPP. Institute fused to one – the AESKU.GROUP.
End of 2015 AESKU.GROUP employed about 144 people.
2016
AESKU. GROUP receives the 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new HELIOS® AUTOMATED IFA SYSTEM with AESKUSLIDES ANA HEp-2-Gamma Assay.
AESKU.Group patricipated in serveral international exhibitions and Congresses like the IGDL Meeting in Germany, the AACC in the US and the Arab Health in Dubai.
The AESKU.AWARD for Lifetime Contribution in Autoimmunity, which was presented on the 10th Congress on Autoimmunity in Leipzig, was given to Dr. Robert Morris, Prof. Angela Tincani and Mr. Poju Zabludowicz for their significant contribution to the field of Autoimmunology.
AESKU organized an prosperous IFA Symposium on the topic Autoimmunity Diagnostics in Frankfurt with the superintendence of Prof. Dr. Torsten Witte, Klinik für Immunologie und Rheumatologie Hannover and the special guest lecturers Prof. Dr. René-Louis Humbel (President of the Groupe d’Etude de L’Auto-Immunité (GEAI)) and Dr. rer. Nat. Elena Csernok, Consultant for the diagnostics of autoimmunity and scientific adviser for the ANCA reference lab, Klinikum Kirchheim.
AESKU.Goup's staff reaches 160 dedicated employees so far
In addition to the international exhibitions and congresses, e.g. the AACC in the United States and the Medlab in Dubai, AESKU.Group usually attends, the company joined the Dresden Symposium on Autoantibodies in Germany.
Launch of the new AESKU.Group homepage. The new, appealing and more responsive page layout enables a richer functionality and User experience on all devices.
Aesku.Group grows further, now welcoming 220 employees of 20 nations.
AESKU.Group acquired food intolerance & allergy specialist DST. DST provides POC tests and owns a database encompassing over 600 Allergens, in-house purified and characterized.
AESKU.Systems expansion: the company tripled its space for research, development and production of lab automation.
) in the interactive HELIOS picture to activate detailed information regarding the serveral HELIOS features.